Economic assessment on the management of chronic lymphocytic leukaemia-Reference-Cited by-同舟云学术

Economic assessment on the management of chronic lymphocytic leukaemia

Published:2005-06 Issue:7 Volume:6 Page:1179-1189
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Goor Kim M,Schaafsma M Ronald,Huijgens Peter C,van Agthoven Michel

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656566.6.7.1179

Reference81 articles.

1. VISSER O, SIESLING S, DUCK JE: Incidence of cancer in the Netherlands 1999/2000. Vereniging van Integrale Kankercentra, Utrecht, The Netherlands (2003).

2. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

3. Clinical staging of chronic lymphocytic leukemia

4. Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia

5. Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic Burden and Quality-of-Life Effects of Chronic Lymphocytic Leukemia: A Systematic Review of the Literature;PharmacoEconomics;2016-01-06

2. Deficiencies of methods applied in cost effectiveness analysis of hematological malignancies;Journal of Cancer Policy;2014-06

3. Economic implications of using bendamustine, alemtuzumab, or chlorambucil as a first-line therapy for chronic lymphocytic leukemia in the US: a cost-effectiveness analysis;ClinicoEconomics and Outcomes Research;2014-04

4. Cost for Treatment of Chronic Lymphocytic Leukemia in Specialized Institutions of Ukraine;Value in Health Regional Issues;2013-09

5. Critical review of economic evaluations in multiple myeloma: An overview of the economic evidence and quality of the methodology;European Journal of Cancer;2011-07